Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
Author:
- D R SuttonDSD R Sutton
Open Access
Abstract
Fifty patients with endoscopically proven gastric ulcers completed a one month double-blind randomised trial of tripotassium dicitrato bismuthate (TBD) (DeNol) compared with an identical placebo. Ulcer healing occurred in 18 (72%) of the 25 patients given TDB and in nine (36%) of the patients given placebo. The TDB group experienced significantly less pain than the placebo group. During a follow-up of 29 patients with healed ulcers for up to 44 months, relapse occurred in 13 (45%). It was highest in the first three months (27%) and had risen to 41% at two years.Keywords
This publication has 14 references indexed in Scilit:
- DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATEThe Lancet, 1981
- Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.Gut, 1980
- Double-blind controlled trial of cimetidine in the healing of gastric ulcer.Gut, 1979
- Cimetidine: an advance in gastric ulcer treatment?BMJ, 1978
- INCREASED HEALING OF GASTRIC AND DUODENAL ULCERS IN A CONTROLLED TRIAL USING TRIPOTASSIUM DICITRATO‐BISMUTHATEMedical Journal of Australia, 1977
- A double-blind gastroscopic study of a bismuth-peptide complex in gastric ulceration.1974
- The Veterans Administration Cooperative Study on Gastric Ulcer. 4. The follow-up period.1971
- Double blind trial of naphthypramide (DA-992) in osteoarthritis.1970
- Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.Gut, 1965
- CLINICAL TRIAL OF A TRITERPENOID LIQUORICE COMPOUND IN GASTRIC AND DUODENAL ULCERThe Lancet, 1962